Chinese expert consensus on the application of immune checkpoint inhibitors in liver transplantation for hepatocellular carcinoma

被引：0
|
作者：
Wang, Zhengxin [1 ]
Yang, Jiayin [2 ]
Li, Guangming [3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Organ Transplantat Inst, Liver Transplantat Ctr,Gen Surg Dept, Shanghai 200040, Peoples R China
[2] Sichuan Univ, West China Hosp, Organ Transplantat Ctr, Chengdu 610044, Sichuan, Peoples R China
[3] Capital Med Univ, Beijing Youan Hosp, Liver Transplantat Ctr, Gen Surg Dept, Beijing 100069, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 18期
基金：
北京市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003237
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2143 / 2145
页数：3
相关论文
共 50 条
  • [41] Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma
    Liu, Tong
    Meng, Guorui
    Ma, Shihui
    You, Junqi
    Yu, Liang
    He, Risheng
    Zhao, Xudong
    Cui, Yunfu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
    Cui, Tian-ming
    Liu, Yao
    Wang, Jia-bei
    Liu, Lian-xin
    ONCOTARGETS AND THERAPY, 2020, 13 : 11725 - 11740
  • [43] Primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma
    Cui, Xiaowen
    Ruan, Minghao
    Li, Yao
    Yang, Cheng
    Zhou, Liuyu
    Zhang, Jin
    Jin, Riming
    Wu, Dong
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
    Liu, Hao-Tian
    Jiang, Meng-Jie
    Deng, Zhu-Jian
    Li, Le
    Huang, Jian-Li
    Liu, Zhen-Xiu
    Li, Le-Qun
    Zhong, Jian-Hong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
    Personeni, Nicola
    Pressiani, Tiziana
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Bozzarelli, Silvia
    Terracciano, Luigi
    Dal Buono, Arianna
    Capogreco, Antonio
    Aghemo, Alessio
    Lleo, Ana
    Lutman, Romano Fabio
    Roncalli, Massimo
    Giordano, Laura
    Santoro, Armando
    Di Tommaso, Luca
    Rimassa, Lorenza
    CANCERS, 2021, 13 (22)
  • [46] Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma
    Chen, Xiu
    Kou, Liqiu
    Xie, Xiaolu
    Su, Song
    Li, Jun
    Li, Yaling
    IMMUNOLOGY, 2024, 172 (01) : 21 - 45
  • [47] Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
    Sangro, Bruno
    Chan, Stephen L.
    Meyer, Tim
    Reig, Maria
    El-Khoueiry, Anthony
    Galle, Peter R.
    JOURNAL OF HEPATOLOGY, 2020, 72 (02) : 320 - 341
  • [48] Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma
    Muhammed, Ambreen
    D'Alessio, Antonio
    Enica, Andrei
    Talbot, Thomas
    Fulgenzi, Claudia Angela Maria
    Nteliopoulos, Georgios
    Goldin, Robert D.
    Cortellini, Alessio
    Pinato, David J.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (03) : 253 - 264
  • [49] The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
    Leone, Patrizia
    Solimando, Antonio Giovanni
    Fasano, Rossella
    Argentiero, Antonella
    Malerba, Eleonora
    Buonavoglia, Alessio
    Lupo, Luigi Giovanni
    De Re, Valli
    Silvestris, Nicola
    Racanelli, Vito
    VACCINES, 2021, 9 (05)
  • [50] Liver transplantation for hepatocellular carcinoma: Time for an international consensus
    Decaens, Thomas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2012, 36 (04) : 316 - 318
12345